Pain medicine

Postoperative Opioid Prescribing Among Adults with Disabilities After a Medicare Opioid Limit Policy

Ann SurgPublished Repeated cross-sectional interrupted time series study

Main finding · Likelihood of initial fill >7-day supplyResult — go to the resultDifference −11.8 pp 95% CI −13.3 to −10.2

Authors' conclusion

The 2019 Medicare 7-day limit was associated with immediate large reductions in initial opioid duration and dosage.

Study context

Population
Adults with disability entitlement aged 18–64 undergoing common surgeries, Medicare Advantage, July 2016-June 202124,910 member-index months
Participants
24,283 adults
Exposure
After vs before the 2019 Medicare 7-day limit on initial opioid prescriptions
Outcome
Opioid duration (initial fill >7-day supply), dosage (cumulative 30-day MME) and subsequent opioid fills
Methodological detailsnational Medicare Advantage claims data
  • National Medicare Advantage claims data

Main finding

Likelihood of initial fill >7-day supply · January 2019

Difference

−11.8 pp

95% CI −13.3 to −10.2

Post 7-day limit vs Predicted
difference −11.8 pp (95% CI −13.3 to −10.2)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeDifference (pp) (95% CI)
Likelihood of initial fill >7-day supply · June 2021Post 7-day limit vs Predicted−5.7 (−7.6 to −3.7)
≥1 fills within 30 days of initial fill · June 2021Post 7-day limit vs Predicted6.9 (3.1–10.7)
OutcomeDifference (MME) (95% CI)
Cumulative 30-day MME · January 2019Post 7-day limit vs Predicted−35.9 (−53.7 to −18.1)
Cumulative 30-day MME · June 2021Post 7-day limit vs Predicted95.2 (56.9–133.6)

≥1 fills within 30 days of initial fill · January 2019

Not significantly different from predicted

Original publication

Postoperative Opioid Prescribing Among Adults with Disabilities After a Medicare Opioid Limit Policy. Ann Surg. Published 8 August 2025. doi:10.1097/sla.0000000000006901

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.